Hanlim Pharmaceutical Co., Ltd.
Records under this name other than the patents Hanlim Pharmaceutical Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.
Showing 1 to 7 of 7 · Back to Hanlim Pharmaceutical Co., Ltd.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,301,954 | Pharmaceutical composition for the prevention or treatment of osteoarthritis containing rebamipide as an active ingredient Lapsed on the fee record Ended Apr 5, 2024 · From the USPTO record | Lapsed on the fee record | Ended Apr 5, 2024 | From the USPTO record |
| US 7,202,365 | Processes for the preparation of S-(-)-amlodipine Term ended Term ended Sep 8, 2023 · From the USPTO record | Term ended | Term ended Sep 8, 2023 | From the USPTO record |
| US 8,859,531 | Pharmaceutical composition including mometasone furoate and azelastine hydrochloride for nasal administration Lapsed on the fee record Ended Oct 14, 2022 · From the USPTO record | Lapsed on the fee record | Ended Oct 14, 2022 | From the USPTO record |
| US 8,691,842 | Pharmaceutical composition for preventing or treating rheumatoid arthritis, containing rebamipide Lapsed on the fee record Ended Apr 8, 2022 · From the USPTO record | Lapsed on the fee record | Ended Apr 8, 2022 | From the USPTO record |
| US 7,579,475 | S-(-)-amlodipine nicotinate and process for the preparation thereof Lapsed on the fee record Ended Aug 25, 2021 · From the USPTO record | Lapsed on the fee record | Ended Aug 25, 2021 | From the USPTO record |
| US 7,279,492 | S-(−)-amlodipine nicotinate and process for the preparation thereof Lapsed on the fee record Ended Oct 9, 2019 · From the USPTO record | Lapsed on the fee record | Ended Oct 9, 2019 | From the USPTO record |
| US 7,482,464 | Processes for the preparation of S-(-)-amlodipine Lapsed on the fee record Ended Jan 27, 2013 · From the USPTO record | Lapsed on the fee record | Ended Jan 27, 2013 | From the USPTO record |